Stocks
Health Care
xtlb
X.T.L. Biopharmaceuticals
TEL AVIV STOCK EXCHANGE: XTLB
+0.10 (+4.20%)
2.48
USD
At close at Apr 17, 20:39 UTC
Income Statement
Revenue
451.00K
Gross Profit
3.00K
Operating Income
-4.47M
Pretax Income
-
Net Income
-6.37M
EBITDA
-6.50M
EBIT
-6.50M
Earnings Per Share
-1.0999999999999999
Balance Sheet
Cash & Cash Equivalents
1.14M
Total Debt
34.50K
Net Cash
-
Net Cash Per Share
-
Equity (Book Value)
3.02M
Book Value Per Share
0.01
Working Capital
-
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.